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Minor Histocompatibility Antigens HA-1-, -2-, and -4-, and HY-Specific
Cytotoxic T-Cell Clones Inhibit Human Hematopoietic Progenitor Cell Growth
by a Mechanism That Is Dependent on Direct Cell-Cell Contact
By W.A.F. Marijt, W.F.J. Veenhof, E. Goulmy, R. Willemze, J.J. van Rood, and J.H.F. Falkenburg
HLA-identical bone marrow transplantation (BMT) may be
complicated by graft-versus-host disease or graft rejec-
tion. Both complications are thought to be initiated by rec-
ognition of minor histocompatibility (mH) antigens by HLA-
restricted mH-antigen-specific Τ lymphocytes. Using
HLA-A2-restricted mH antigens HA-1-, -2-, and -4-, and
HY-specific cytotoxic Τ lymphocyte (CTL) clones, we stud-
ied the recognition by these CTL clones of interleukin-2
(IL-2)-stimulated Τ cells (IL-2 blasts), BM mononuclear
cells (BMMNCs), and hematopoietic progenitor cells
(HPCs). We showed that, when IL-2 blasts from the BM
donors who were investigated were recognized by the HA-
1-, -2-, and -4-, and HY-specific CTL clones, their
BMMNCs and HPCs were recognized as well by these CTL
clones, resulting in antigen-specific growth Inhibition of
erythrocyte burst-forming units (BFU-E), colony-forming
units-granulocyte {CFU-G), and CFU-macrophage (CFU-
M). The HA-2-specific CTL clone, however, inhibited BFU-
E and CFU-G growth from four donors to a lesser extent
than from two other donors. We further investigated
whether inhibitory cytokines released into the culture me-
dium by the antigen-specific stimulated CTLs or by stimu-
lated BMMNCs were responsible for suppression of HPC
growth or whether this effect was caused by direct cell·
cell contact between CTLs and HPCs. HPC growth Inhibi-
tion was only observed after preincubation of BMMNCs
and CTLs together for 4 hours before plating the cells in
semisolid HPC culture medium. When no cell-cell contact
was permitted before plating, neither antigen-stimulated
CTL nor antigen-nonstimulated CTLs provoked HPC
growth Inhibition. Culturing BMMNCs in the presence of
supernatants harvested after incubation of BMMNCs and
CTL clones together for 4 or 72 hours did also not result in
HPC growth Inhibition. Both suppression of HPC growth
and lysis of IL-2 blasts and BMMNCs in the 51Cr-release
assay appeared to be dependent on direct cell-cell contact
between target celts and CTLs and were not caused by the
release of inhibitory cytokines into the culture medium by
antigen-specific stimulated CTLs or by stimulated
BMMNCs. Our results show that mH-antigen-specific
CTLs can inhibit HPC growth by a direct cytolytic effect
and may therefore be responsible for BM graft rejection
after HLA-identical BMT.
© 1993 by The American Society of Hematology.
HLA-IDENTICAL bone marrow transplantation(BMT) is frequently complicated by acute graft-ver-
sus-host disease (GVHD). To decrease the incidence and
severity of acute GVHD, BM grafts are depleted of mature
Τ cells.1'2 However, T-cell depletion is associated with an
increased incidence of graft rejection and graft failure.3"6
Immunologically mediated graft rejection is thought to be
caused by residual immunocompetent recipient Τ cells that
recognize allo-antigens expressed on donor hematopoietic
progenitor cells (HPCs). After haploidentical or partially
matched unrelated BMT, these Τ cells may recognize HLA
class I or II antigens.7"9 After HLA genotypically identical
BMT or matched unrelated BMT, residual host Τ cells may
react with minor histocompatibility (mH) antigens ex-
pressed on donor cells.10 mH antigens are presented in the
context of HLA antigens to HLA class I or II restricted mH-
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antigen-specific Τ cells."·'2 It is important to know whether
mH antigens expressed on human HPCs can be recognized
by mH-antigen-specific cytotoxic Τ lymphocytes (CTLs)
and by what mechanism such CTLs suppress HPC growth.
It might then bc possible to anticipate or prevent the occur-
rence of graft rejection after HLA-identical BMT by resid-
ual recipient antidonor CTL.
Previously, we have shown the recognition of human
HPCs by HA-3 and HY-specific CTL lines.13·14 Expression
of HA-1, -2, -4, and -5 could not be clearly shown, although
at high effectontarget (E:T) ratios and after prolonged incu-
bation times partial Inhibition of HPC growth was ob-
served. However, it has been shown that increased E:T ra-
tios result in increased antigen-nonspecific Inhibition of
HPC growth.15 Based on these results, we concluded that
mH antigens may be difFerentially expressed on human
HPCs. Recently, we showed the recognition of clonogenic
leukemic precursor cells by HA-1 -, -2-, -4-, and -5-specific
CTL clones.16 Furthermore, we have reported the recogni-
tion of HPCs by an mH-antigen-specific CTL line.17 This
CTL line appeared to recognize a large panel of unrelated
HLA-A2-positive individuals in a pattern analogous to the
distribution ofthe mH antigen HA-2 expression in the popu-
lation.18 We therefore hypothesized that the lack of recogni-
tion by the HA-2-specific CTL line in the previous study14
may have been caused by relatively low frequencies of the
respective mH-antigen-specific CTLs to ensure a sufficient
E:T ratio to inhibit HPC growth. The recent cloning ofthe
mH antigen HA-1-, -2-, -4-, and -5-, and HY-specific CTL
lines18 provided us with sensitive cellular reagents to rein-
vestigate the expression of mH antigens on HPCs in more
detail.
Conflicting reports have been published about the mecha-
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Fig 1. Reeognition of different target cells from
one donor by the HA-4—specific CTL clone using
three E:T ratios ([DJ 0.3:1, [D] 1:1, [•] 3:1). BFU-E,
CFU-G. and CFU-M were tested in the HPC growth
Inhibition assay, and IL-2 blasts and BMMNCs in
the 51Cr-release assay.
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nism οΓ HPC growth suppression by effector cell popula-
tions. For instance, CTLs may produce a variety of cyto-
kines on antigen-specific Stimulation by target cells."'22
Alternatively. CTLs may stimulate target BM mononudear
cells (BMMNCs) to produce cytokines. Thus. ineubation of
CTLs with BM target cells may result in HPC growth Inhibi-
tion caused by a suppressive effect of cytokines, as reported
by other investigators.21·23 On the other hand, cell-cell con-
tact between CTLs and antigen-positive target cells leads to
CTL Stimulation, resulting in direct target cell death.24"26
We and others have illustrated that cell-cell contact is im-
portant to obtain HPC growth Inhibition, suggesting that
the suppression may be caused by target cell lysis.15·27 How-
ever, Bunjes et alM showed that both reeipient peripheral
blood lymphocytes (PBLs) collected aftcr BM graft rejeetion
as well as supernatants harvested after ineubation of reeipi-
ent PBLs in medium alone or in the presence of concanava-
lin Α (con A) suppressed HPC growth.
In this study, we describe, using the HLA-A2~restrieted
mH antigen HA-1-, -2-, and -4-, and HY-specific CTL
clones, the recognition of these mH antigens on interleukin-
2 (IL-2) blasts, BM cells, and HPCs. Wc show that antigen-
speeifie growth Inhibition of HPCs requircs direct ccll-ccll
contact between HPCs and CTLs and is not caused by secre-
tion of HPC growth-inhibitory cytokines by antigen-speeifi-
cally stimulated CTLs or activated target cells.
MATERIALS AND METHODS
Colleclion of cells. Normal human BM was obtained, after in-
formed consent, from donors for BMT by aspiration from the postc-
rior iliac crests. BMMNCs and PBLs werc isolatcd and cryopre-
served as described.17 PBLs were thawed immediately before usc
and resuspended in RPM1 plus 15% pooled human serum (RPMi
plus serum). BMMNCs were thawed, washed, and eultured for 18
hours in RPMI plus 15% human serum before use.
II LA types of BM donors The HLA types of the BM donors
were donor I: AI/2. B8/35, C4/7, DR3/8, DQ2; donor 2: Α1/2,
B8/15, C3/7, DR3/4. DQ2/3: donor 3: Al/2, B17/35, C4/6, DR7/
8, DQ3; donor 4: Α1/2, B8/40, C2/7, DR3/4, DQ2/3; donor 5: A2,
Β15/40, C2/3, DR5/7/11, DQ2/3/7; and donor 6: A2/28. B37/53,
C4/6, DR9/13, DQI/3.
uCr-H'lease assay. Target cells were either BMMNCs or recom-
binant IL-2 (rlL-2)-stimulated Τ cells (IL-2 blasts) that were gener-
ated by eulturing IQ7 PBLs in 10 mL RPMI plus 15% serum and
0.2% phytohemagglutinin (ΡΗΛ: Difco Laboratories, Detroit. MI)
for 3 days. The cells were then washed and further eultured in the
absence of ΡΗΛ in medium consisting of RPMI plus 15% serum
and 300 IU rIL-2/ml (T-cell eulture medium). After 2 to 3 days of
eulture, the cells were used as targets in a 5lCr-release assay.
HA-I-, -2-, and -4-, and HY-specific CTL clones, generated as
described,18 and HLA-A1- and -A2-specific CTL clones were eul-
tured in T-cell eulture medium. They were used as effector cells 7
days after Stimulation with irradiated (50 Gy) Epstein-Barr virus
(EBV)-transformed Iymphoblastoid cell lines (EBV-LCLs) derived
from the original stimuiator cells and allogeneie PBLs. Eighteen
hours before use, fresh T-cell eulture medium was added to the
CTL clones in the absenee of feeder cells. Standard "Cr-release
assays were performed as described2' at E:T raiios of 2:1, 1:1. and
0.3:1.
HPC growth Inhibition assay. BMMNCs were depleted of Τ
cells by 2-aminoethylisothiouroniumbromide-pretreated sheep red
blood cells as described."1 Α quantity of 1.25 x 10s BMMNCs in 0.1
mL HPC cuiture medium consisting of IMDM supplemented with
30 vol% blood group AB heparin plasma and 0.5% bovine serum
albumin (BSA), 0.47 g/L transferrin, and 5 Χ Ι0"5 mol/L mercap-
toethanol was mixed with 0.1 mL of HPC eulture medium contain-
ing CTLs at E:T ratios of 2:1, 1:1, and 0.3:1. CTLs were irradiated
(20 Gy) before use to prevent colony formation by these cells. The
cell mixture was centrifuged (1,000g for 15 seconds) to establish
direct cell-eell contact between CTLs and BMMNCs and then ineu-
bated for 4 hours in a fully humidified atmosphere of 5% CO2 at
37°C. After ineubation, the eells were resuspended at a final vol-
ume ofl .4 mL of HPC eulture medium supplemented with glycosi-
lated recombinant granulocyte-macrophage colony-stimulating
factor (rGM-CSF; Sandoz Ltd, Basel, Switzerland) at a final con-
centration of 10 ng/mL. rIL-3 (Sandoz) at a final concentration of
50 ng/mL, 2 IU of recombinant erythropoietin (Cilag AG Interna-
tional, Zug, Switzerland), and methylcellulose at a final concentra-
tion of 1.3%. Subscquently, 1.15 mL of this Suspension was plated
in 30-mm plastic dishes, ineubated in a fully humidified atmo-
sphere of 5% COi and 37"C, and eultured for 18 days. The number
of erythroeyte burst-forming units (BFU-E), colony-forming units-
granulocyte (CFU-G), and CFU-macrophage (CFU-M). defined as
cell aggregates of more than 20 eells, were scored on day 18 under
an inverted microscope, To establish the necessity for direct cell-cell
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Fig 2. Reeognition by the HLA-A1- and -A2-specifie CTL clones of
(α; BMMNCs and (H) IL-2 blasts (tested in the "Cr-reiease assay and
expressed as a porcentage of lysis) and on (Ω) BFU-E, (iä) CFU-G,
and (H! CFU-M (tested in the HPC growth Inhibition assay and
expressed as a percentage of growth Inhibition relative to HPC
growth of untreated control BMMNCs). E:T ratio shown is 2:1.
contact between CTLs and BMMNCs. and to e\elude the povsihil-
it> of antigen-nonspeeific Inhibition of UPC growth caused by tlic
presence of C'ILs in the semisolid culture mucitum. CTLs and
BMMNCs werc sepanudy preineubated for 4 hoursand mixcd im-
mediately beforc plating.
To analyze whethet solublc factors. secreted dunng the ineuba-
tion period. werc responsible for antigen-specific HPC growlh inhi-
buion. three different protocols wese used. First, 5 χ 104 trradiated
BMMNCs and 1 χ lO'irradiatcdCTLsvvereincubated forcithcr4
or 72 hours in Κ PC culturc nieduim in a fullv humidificd atmo-
sphereeonsi,sti'i{;oi"5%CO,>at370C. Subsequently. supernatanlsof
thi$ cell mixtare «erc added to 5 χ 10" BMMNCs. from the same
BM donor a nd. aftcr 18 days of cultii re, UFU-B, CFU-G. and C R )-
Μ colonics werc scored, Sccond. irradiated BMMNCs werc added
to CTLs and tntubated for 4 hours. Subsequcnily. ihese antigen-
specific stimulatcd C"I Ls were added to nonirradiated BMMNCs
from ihesame donor immcdiatel> before plating and, after iSdass.
ofeulture, BFU-E, Cf;U-C5, and CFU-M colomeswese scored. "Ιο
control for cell crowding effects. BMMNCs and CTLs weie incu-
bated for 4 hotirs, irradiatal BMMNCs from the same donor wero
added, the cell mivture was platod. and, after 18 days ofeulture.
BFU-K, CFU-G, and CFl'-M coionks were scored. Third, ιο e.\-
ciude the pos,sibiliu oflfPCgfowth Inhibition caused by labile fac-
tors, inadiatcd antigen-posithe BMMNCs, irradiated antig«n-spe-
eific CTLs. and noniiradiated antipen-negatixe BMMNCs werc
mcubaicd foi 4 hourb. plated, and, .vttci 18 daysof cultuic. BFU-F,
CHJ-G. and CF'U-M colonies werc scored. Alternativen, irraduued
antigen-sjXTific CTJ s and antigen-negativc BMMNCs weie inai-
bated for 4 hours, plated, and, after 18 davs ofeulture. BFU-F,.
CFU-G. and CFU-M colonies werc scored As a control forantigen-
spccific HPC growth Inhibition, nonirradiated antigen-posuive
BMMNCs and irradiated antigen-speeifie CTI s were meubated for
4 hours, plated, and. after 1Η Jays. of cultuie, BFU-E, CFU-G, and
CMJ-M colonics were scored.
RESULTS
mlluniigeni //.!-/, -2. und-4. und//}'an1 exprc.twdon
JJPC. In Fig I. a repräsentative exampie of the dosc-de-
pendent lysis of BMMNCs and IL-2 blasts and growth Inhi-
bition of Η PCs by the mil antigen HA-4-specific CTL
clone is shown. CFl i-M and CFU-G growth Inhibition was
still maximal at low E:T tatios, ilkistrating the high sensitiv-
ity of this assay. in euch experiment. IL-2 blasts, BMMNCs,
and l (PCs from a Single BM donor were used as target celis,
and the HL Α-Λ1- and -Λ2-. I iA-1 ~-, -2-, and -4-, and HY-
speetfie CTI. clones as eflcctor cells in E:T ratios of 2: i, ! : ! ,
and 0.3:1. Results obtained with an f::T ratio of 2:1 are
displayed in Figs2. 3,and 4. BMMNCs. H.-2 blasts, BFU-F.,
OFU-ü, and CFU-M from all sK BM donors tested were
recogm/ed by the [ILA-A2- (l-'ig 2B), and rnll antigen HA-
2-specifk· CTL clones (Fig 3B). Ail target cells from donors
1. 2, 3, and 4 were reeognimi by the ΗΙΛ-Λ 1-specilk CTL
cione (Fig 2A). The mll antigen ΗΛ-1-spccific CTL clone
reeognized all target cells from donors 1, 2, 3. and 6 (Fig
3Λ). All target cells from donots 4, 5. and 6 were recogm/ed
by the niH antigen HA-4- and i lY-speeific CTL eloncs. the
latter also recogni/ing all target cells from donor 2 (Fig 3C
and D). Target cells from donor 1 could not be tested b\
thesc two CTL clones, The recognition of IL-2 blasts by the
HLA-AI - and -A2-, ml I antigens ΗΛ-1- and -4-. and HY-
speeitic CTL clones correlated with the recognition of
BMMNCs. BFU-E, CFU-G, and CFU-M by these CTL
clones. The highly Ktic ULA-AI- and HA-1-specitk CTL
clones showed liimtcd antigcn-nonspccific HPC growth In-
hibition in some Hl Λ-Α1- or HA-1-negative donors (do-
nors 5 and 6 and donors 4 and 5, respeclively). whereas no
signilkant Issis of thcir IL-2 blasts and BMMNCs was dc-
tected. Recognition of target cells from the HI A-Al-posi-
tive donors 1 through 4 by the i U Λ-Α1 -specinc CTL elone
(Fig 2A) and from the HLA-A2-positive donors 1 through 6
by the HLA-A2-specific CTL clone (Fig 2B) providcd the
positive conlrols for the assays. The negative controls were
formed by efleexor-target cell combinations of which the
target cell lackcd eilher the HLA restriction Clement or the
mH antigen. eg, donors 5 and 6 in Fig 2Λ, donors 2 and 3 in
Fig 3C, and the fcmalc donor 3 in Fig 3D.
The ΗΛ-2-spccific CTL clone rocognized IL-2 blasts.
BMMNCs, BFU-F., CFU-G. and CFU-M from all donor.s
(Fig 3B). Howevcr, BFU-Π and CFU-G from donors 3
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Fig 3, Reco0nition by the
HA-1-, -2-, and -4-, and HY-
specifie CTL clones of (Dl
BMMNC, (β) IL-2 biast$, ( U
BFU-E, (Bi CFU-G, and {•) CFU-
M. For deteils see legend to Fig
2.
HA-4 D HY!A2)
througli 6 wcrc rccogni/'ed to a lesser extent. The overall
percentage lysis of BMMNCs from the donors by thc
ΗΛ-2-specific CTL clonc was also lowcr than thc percent-
age lysis of BMMNCs by the other CTL clones. Η PCs fiom
donors 3 through 6 wcrc clearly recogni/cd by other C Π.
clones whenever they expressed thc appropriate antigen.
Impaired exprcssion of the Η1.Α-Λ2 resirietion moleculeon
HPCs of the ΗΛ-2-positiU" indiv iduals appeared not to be
an explanution for thc dtminished or abheilt recogmtion. a.s
shown by the high perccntage ofgrowth Inhibition of HPCs
from donors 3 through 6 by the HLA-A2-specific C'IL
clonc (Fig 2B).
lll'C growth Inhibition depeiuh an direel cell-cc!!
com an 'fable 1 and Figs 4 and 5 show thc results ofthe
expcrimenls performed to invesligatc whether dircci cell-
eeii contact was neeessary to inhibit HPC growth or whether
cytokines produced by antigen-speeifieally stimulated CTL
οι aethated target cells were responsiblc ibr suppression of
HPC growth. Supernatants harvested after 4 hours (Lig 4A
and B: row IV) or 72 hours (Tablc I) of ineubation of eflcc-
tor and target cells did not inhibit HPC growth. Preincubat-
mg CTLs and BMMNCs scparately before plating, thus
avoiding antigen-specific Stimulation, inhibilccl HPC
growth onty to a limited extent (Fig4A and B; row I). CTL
that were antigen-specifically sümulated by preineubation
with irradiated BMMNCs and were mixed immediately be-
fore plating with nonirradiatcd BMMNCs did not inhibit
UPC growth either (Fig 4Λ and B: row III). However. only
after CTLs and BMMN( s were preineubated for 4 hours
was signiüeant antigen-specific HPC growth Inhibition ob-
served (f-ig 4A and B: row 11); the addition of irradiated
BMMNCs to control for cell-crowding effects diel not influ-
ence HPC" growth Inhibition. Figure 5 shows that ineuba-
tion for 4 hours ofthe HLA-A2-restricted FiA-2-specific
C'l Lswith(Fig5, row I)orwithout(Fig5.rowll)HA-2-pos-
itive irradiated BMMNCs and HLA-A2~negative nonirra-
diated BMMNCs did not mduce HPC growth Inhibition,
ineubation of nonirradiatcd ΗΛ-2-positive BMMNCs with
irradiated ΗΛ-2-speedic CTLs for 4 hours resulted in al-
most complete HPC growth Inhibition (Fig 5. row III).
The.se icstilts illustrate that HPC growth Inhibition by HLA
class 1 and mH-antigen-specific CTL clones IS not caused
by soluble factors released into the eulture mediuni but that
direet cell-cell eontact betwecn HPCs and CTLsisrequired.
DISCUSSION
In this report, wc show the recognition of mH antigens on
IL-2 btasts. BMMNCs. and HPCs by the HLA-A2-rc-
stricted mH antigen HA-1-. -2-. and -4-, and HY-specitic
CTL clones. Previously. we reported the recognition of hu-
man 11 PCs b\ ( T l . lines specific for the ΗΙ ,Λ-Α 1 -restricted
mH antigen ΙΙΛ-3 and the 1 Π.Λ-Λ 1-, Λ2-. or B7-restricted
ml I antigen HY, but not by the II A-l -. -2-, -4-, and -5-spe-
eific C'l L lines.1! l 4 In that report, recognition of ilPCs by
ΗΛ-1-, -2-, -4-, and -5-specitic CTL lines could only be
cletected to a limited extent using high E:T ratios, rcsulting
in significant antigen-nonspeeme HPC growth Inhibition.
This antigen-nonspednc suppression of HPC growth may
have becn caused by high concentrations of cytokines» pto-
dueed by thc large nuniber of CTLs present in the eultures.
thus inducing decreased sensilivity and speeificity of thc
cellular assay. All IIPC growth Inhibition assuys in these
studies were performed using CTL lines. CTL lines may
consist of multiple clones with difierent speeificities result-
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Fig 4. Direct ceil-cell contact-dependent HPC growth Inhibition
by HU-A2- (A) and HA-1-specffic (B| CTL clones. (I) BMMNCs and
CTLs wore preincubated separately and mixed immediately before
piating. (II) BMMNCs and CTLs were first preincubated together for
4 hours and then irradiated BMMNCs were added a$ a control for
cell-crowding effects. Thereaftor, the cell suspensions were culturecl
for HPC growth. Uli) Irradiated BMMNCs were incubated with CTLs
for 4 hours and then nonirradiated BMMNCs were added and the
cell suspensions were cultured for HPC growth. (IV) CTLs were
incubated with BMMNCs in HPC culture medium for 4 hours,
wheraafter the supernatants were harvested, added to BMMNCs
from the same donor, and cultured for HPC growth. Bars represent
the tnean of two experiments. E:T ratio is 2:1. (Dt BFU-E; SB) CFU-G;
(•ICFU-M.
mg in a "dilutkm" of the iclcvint CTL clonc and, conse-
qucntlv, in a lowcr E.T ratio. This "dilutkm" re.su hsappar-
cntly not in deercased lysis or rocognition when the tatget
cell Suspension is reialively homogencous. a& is the casc with
1L-2 blasls. l Iowever, HPC\ as target cells do not only oeeur
ai a low (requency of [% in BM eell suspensions (500 colo-
nics tbrmed by 5 X 104plated BMMNCs) binare also mixed
with 99l& BM eells expressing the relevant antigen and thtis
funetioning as "cold targets." 'i he ΗΛ-3- und the HY-spe-
etfie C'I1. Smes studied previously were highly cytotoxic,
and this may have compensated for the low E:T ratios. Vs-
mg the HA-1-. -?.-. and -4-, and H Y-specific CTL ebnes.18
m.stead of CTL hncs. the sensitivity of the assas appeared to
be signifieantly improved. Recognition of IL-2 blasts and
BMMiNCs from the donor.s tested in tiie 5lCr-release assaj
b> the ml ϊ-antigen-spccilk CTL clones was associated with
growth Inhibition oi'HPCs trom the samc donor. In some
inManc.es, lhelL-2 blasts as well as the BMMNCsand IIPC's
were not recognt/ed by the mH-antigon-spccific CTL
clones, sugge.stmg that these donois laeked e\pres$ion of the
ml i antigen on their h mpha-hematopoietic cetls. However,
the HA-2-specitie CTL clonc iccogni/cd BFU-E and CFU-
G dorn donors ί thiough 6 to a lesser extent. Lysis of
BMMNCs from all donors b\ the ΗΛ-2-specific Cl'Ls was
lower us, well. This was not caused by dtminished sensitivity
to lysis of BMMNCi. BMJ-Ε, and CFU-G fiom these do-
nors. as these targets were clearK recognu.ed by olhcr CTL
clones, eg, ΗΛ-4 - and HY-speafic C'I Ls. Deeieased cx-
pression of the HLA~A2 restrielion Clement was theicfore
also not an explanation for this lack of Η PC growth inhibi-
tjon. a.s was further shown by the effective Inhibition of
HPC giowth of the same donors by the anti-HLA-A2
CTI s. Van der Harst et aP1 obvcrved that the HA-2-specific
CTL clone reeogni/ed Ivmpliocytic leukemia eellsless well.
They found that these target cells cvhibited low surfacc e.\-
pression of the ndhesion molccules CDllu/CD18 eom-
paied with target cells that weie well reeogm/ed. Low .sur-
face expiession of adhesion moleculei was prohabK not an
explanation for the low percentage of growth Inhibition of
BFU-F. and CFU-G in our stud\ becausc each donor was
analyzed with all mll-antigen-spccihc CTL clones, The
other mH-antigen-spccific CTL clones were capable of in-
ducing Strang gtowth Inhibition of BFU-F. and CFt'-G from
donors 3 through 6. Alternativel>, the llA-2-specttic CTI
clone ma> be more sensitiv e to impaired adhesion molecule
interaction. Üecreased recognition of BFU-F. and CFU-G
from these donors b> the ΗΛ-2-speciik- CTI clone may
have been caused b\ u nuniber of other factors either acting
alone or in comhmation. I-irst. it mighl be rclatcd to differ-
entiation and/or maturation of HPCs, rcsulting in either a
loss of ΗΛ-2 exprcssion on cells of eruhroid and granulo-
cytic lincage or an mercasc of evpression on lymphocytes
and macrophages. Differential c\pression of rnH antigens
on celks fiom vanous tissues has recently been shown by de
Bueger et al.·52 HA-l and -2 could only be detected on eells
of lymphocyüc origin and monocytes and not on keratino-
cytes, melanocytcs, dermal fibioblasls, kidney epithelial
celis, and endothehal cells. Second. expression of HA-2 mas
be lower on diffetent cell tjpcs because of competition with
other eeli-type-speeilie peptides for hinding to Η LA mole-
Table 1 Absence of HPC Growth Inhibition After Incubation of
BMMNCs With Supematant Harvested After Incubation of mH-
Antigen-Specific CTLs With mH-Antigen-Positive BMMNCs
CTLi.
SpßCfflG
for
HA 1
HA-2
HA 4
BMMNCs.
Hosmvc
for
HA 1
HA-2
HA-4
BFUE
89
99
88
% HPC Coiony Growth
CFU-u
111
88
86
CFU-M
1/5
13?
102
Valucs are supematant induced HPC growth as a porcemage of con-
troi HPC growth Control HPC growth wds oboineci by culturing of
BMMIMCs in the presenco of 1L-3. GM-CSF, and erythropoietin Reiults
represent the mean of two expenmonts
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HA-2
Fig 5 Direct cell-cell contact-dependent HPC
growth Inhibition by HA-2-speciflc CTL clone Ir-
radiated HA-2-posrtive BMMNCs, HLA-A2-restricted
HA-2-spedfic CTLs, and nonirradiated HLA-A2-
negative BMMNCs were incubated for 4 hours,
plated, and cultured for HPC growth (row I)
Alternativaly, HA-2-specific CTLs and nonirradiated
HLA-A2-negative BMMNCs were incubated for 4
hours, plated. and cultured for HPC growth (row II)
As a control for antigen-speclfic HPC growth In-
hibition, nonirradiated antigen-positive BMMNCs
and antigen-specific CTLs were incubated for 4
hours, plated, and cultured for HPC growth (row III)
Bars represent the results of one experiment at an
Ε Τ ratio of 3 1. (•) BFU-E, (S) CFU-G, (•) CFU-M
100 -f
8 0 -
60 -
40
2 0 -
% growth Inhibition
cules Third, expression of HA-2 may depend on expression
of another gene product, comparable with expression of the
Lewis blood group antigens on erythrocytes being depen-
dent on the secretor genes "
It has been postulated that HPC growth Inhibition by
antigen-specific effector cells is mediated by cytokines se-
creted mto the culture medium and not by target cell lysis
after cell-cell contact between effector and target cells Anti-
gen-specific CTLs produce interferon-γ and tumor necrosis
factor-0, factors that are inhibitory for HPC growth34"36
However, they may also produce GM-CSF and IL-2, -3, -4,
-5, and -6, of which GM-CSF, IL-3, and IL-5 are potent
stimulators of HPC growth 37J1° IL-4 enhances G-CSF-in-
duced CFU-G growth, but is inhibitory for CFU-M
growth 4 1 In the present study, supernatants containing cy-
tokines presumably produced by antigen-specific sümu-
lated CTLs that were harvested after incubation penods of 4
or 72 hours were shown not to be inhibitory for HPC
growth Additionally, antigen-specific stimulated CTLs did
not mhibit HPC growth when direct cell-cell contact was
omitted by preincubatmg CTLs and BMMNCs separately
before mixing and plating the cell suspensions Even Stimu-
lation of CTLs by irradiated BMMNCs or Stimulation of
BMMNCs by CTLs and the hkely subsequent production or
alteration of production of cytokines mduced no HPC
growth Inhibition both of antigen-positive BMMNCs and of
antigen-negative BMMNCs Recognition of target cells by
CTLs after estabhshmg direct cell-cell contact will result in
direct target cell death24"26 The inhibitory effect on HPC
growth by the CTLs appeared to have taken place dunng the
4-hour incubation penod, and is thus hkely to be similar to
the lytic effect of the CTL clones on the 51Cr-labeled mature
BMMNCs In contrast to the 51Cr-release assay, the HPC
growth Inhibition assay measures funcüonal capacity of
HPCs, present at low frequency in BMMNCs, and may be a
better reflection of the in vivo Situation
BM graft rejection after HLA-identical BMT is thought to
be caused by mH-antigen-specific CTLs These CTLs have
been isolated from recipient PBLs in some cases and were
inhibitory for donor HPC growth in vitro after estabhshmg
cell-cell contact (Manjt et al, manuscnpt submitted)!02842
Because of recognition of HPCs by all mH-antigen-specific
CTLs tested so far and the high probability of mH antigen
dispanty between HLA-identical sibhngs,43 ** many BM
graft recipients are hkely to be at high nsk for BM graft
rejection Eradication of residual recipient antidonor CTLs
by the conditionmg regimen and possibly by the posttrans-
plant immunosuppression is essential for engraftment, ex-
cept perhaps m homozygotic twm transplantation.
In conclusion, we have shown the expression of the mH
antigens HA-1, -2, and -4, and HY on IL-2 blasts,
BMMNCs, and HPCs We showed that, for HPC growth
Inhibition, direct cell-cell contact between HPCs and CTLs
dunng the preincubation penod is required, and that this
suppression is not caused by secreted cytokines BM graft
rejection after HLA-identical BMT may therefore be caused
by a direct cytotoxic effect of recipient CTLs that recognize
mH antigens expressed on donor HPCs
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